Green Cross Corporation (006280.KS)
006280.KS Stock Price Chart
Explore Green Cross Corporation interactive price chart. Choose custom timeframes to analyze 006280.KS price movements and trends.
006280.KS Company Profile
Discover essential business fundamentals and corporate details for Green Cross Corporation (006280.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Jan 2000
Employees
2.01K
Website
https://www.globalgreencross.comCEO
Il-Sup Huh
Description
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. The company was formerly known as Sudo Microorganism Medical Supplies Company and changed its name to Green Cross Corporation in 1971. Green Cross Corporation was founded in 1967 and is headquartered in Yongin-si, South Korea. Green Cross Corporation is a subsidiary of Green Cross Holdings Corporation.
006280.KS Financial Timeline
Browse a chronological timeline of Green Cross Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 23 Jan 2026
Upcoming earnings on 30 Oct 2025
EPS estimate is ₩1.31K, while revenue estimate is ₩486.67B.
Earnings released on 1 Aug 2025
EPS came in at ₩3.33K surpassing the estimated ₩1.31K by +153.53%, while revenue for the quarter reached ₩500.26B , missing expectations by -0.11%.
Earnings released on 30 Apr 2025
EPS came in at ₩2.60K surpassing the estimated -₩1.05K by +348.01%, while revenue for the quarter reached ₩383.78B , missing expectations by -14.75%.
Earnings released on 24 Jan 2025
EPS came in at -₩2.39K falling short of the estimated ₩759.00 by -415.08%, while revenue for the quarter reached ₩440.85B , beating expectations by +2.29%.
Dividend declared on 27 Dec 2024
A dividend of ₩1.50K per share was announced, adjusted to ₩1.50K. The dividend was paid on 1 Apr 2025.
Earnings released on 1 Nov 2024
EPS came in at ₩2.92K surpassing the estimated ₩1.01K by +190.05%, while revenue for the quarter reached ₩464.90B , missing expectations by -0.39%.
Earnings released on 5 Aug 2024
EPS came in at -₩608.00 falling short of the estimated ₩758.94 by -180.11%, while revenue for the quarter reached ₩417.40B , missing expectations by -7.99%.
Earnings released on 2 May 2024
EPS came in at -₩2.22K falling short of the estimated -₩197.50 by -1.02K%, while revenue for the quarter reached ₩356.81B , missing expectations by -2.10%.
Earnings released on 31 Jan 2024
EPS came in at -₩1.74K falling short of the estimated -₩433.50 by -301.58%, while revenue for the quarter reached ₩404.94B , missing expectations by -1.21%.
Dividend declared on 27 Dec 2023
A dividend of ₩1.50K per share was announced, adjusted to ₩1.50K. The dividend was paid on 5 Apr 2024.
Earnings released on 1 Nov 2023
EPS came in at ₩1.22K falling short of the estimated ₩2.43K by -49.71%, while revenue for the quarter reached ₩439.35B , missing expectations by -4.78%.
Earnings released on 1 Aug 2023
EPS came in at ₩155.00 falling short of the estimated ₩1.30K by -88.05%, while revenue for the quarter reached ₩432.87B , missing expectations by -0.40%.
Earnings released on 2 May 2023
EPS came in at -₩1.97K falling short of the estimated -₩76.14 by -2.48K%, while revenue for the quarter reached ₩349.48B , missing expectations by -9.18%.
Earnings released on 14 Feb 2023
EPS came in at ₩755.00 surpassing the estimated ₩500.16 by +50.95%, while revenue for the quarter reached ₩411.47B , beating expectations by +8.75%.
Dividend declared on 28 Dec 2022
A dividend of ₩1.75K per share was announced, adjusted to ₩1.75K. The dividend was paid on 7 Apr 2023.
Earnings released on 1 Nov 2022
EPS came in at ₩3.29K falling short of the estimated ₩4.09K by -19.54%, while revenue for the quarter reached ₩459.67B , missing expectations by -2.58%.
Earnings released on 1 Aug 2022
EPS came in at ₩1.13K surpassing the estimated ₩629.00 by +80.13%, while revenue for the quarter reached ₩423.23B , missing expectations by -0.51%.
Earnings released on 2 May 2022
EPS came in at ₩559.85 falling short of the estimated ₩897.00 by -37.59%, while revenue for the quarter reached ₩416.94B , beating expectations by +8.98%.
Earnings released on 14 Feb 2022
EPS came in at ₩4.53K surpassing the estimated ₩657.00 by +589.59%, while revenue for the quarter reached ₩402.29B , missing expectations by -16.45%.
Dividend declared on 29 Dec 2021
A dividend of ₩2.00K per share was announced, adjusted to ₩2.00K. The dividend was paid on 4 Apr 2022.
Earnings released on 1 Nov 2021
EPS came in at ₩4.71K , while revenue for the quarter reached ₩465.71B .
Earnings released on 30 Jul 2021
EPS came in at ₩267.00 , while revenue for the quarter reached ₩387.60B .
Earnings released on 29 Apr 2021
EPS came in at ₩1.29K surpassing the estimated ₩981.05 by +31.80%, while revenue for the quarter reached ₩282.23B .
Earnings released on 9 Feb 2021
EPS came in at ₩1.29K falling short of the estimated ₩3.47K by -62.78%, while revenue for the quarter reached ₩416.73B .
Dividend declared on 29 Dec 2020
A dividend of ₩1.50K per share was announced, adjusted to ₩1.50K. The dividend was paid on 2 Apr 2021.
Earnings released on 2 Nov 2020
EPS came in at ₩5.34K surpassing the estimated ₩3.17K by +68.28%, while revenue for the quarter reached ₩419.58B .
006280.KS Stock Performance
Access detailed 006280.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.